Human leukotriene C4 (LTC4) synthase was purified >25,000-fold to homogeneity from the monocytic leukemia cell line THP-1. Beginning with taurocholatesolubilized microsomal membranes, LTC4 synthase was chromatographically resolved by (s) anion exchange, (ig) affinity chromatography (through a resin of biotinylated LTC2 immobilized on streptavidin-agarose), and then (id) gel ifitration. The final preparation contained only an 18-kDa polypeptide. The molecular mass of the pure polypeptide was consistent with an 18-kDa polypeptide from THP-1 cell membranes that was specifically photolabeled by an LTC4 photoaffinity probe, 12SI-labeled azido-LTC4. On calibrated gel-filtration columns, purified LTC4 synthase activity eluted at a volume corresponding to 39.2 ± 3.3 kDa (n = 12). The sequence of the N-terminal 35 amino acids was determined and found to be a unique sequence composed predominantly ofhydrophobic amino acids and containing a consensus sequence for protein kinase C phosphorylation. We therefore conclude that human LTC4 synthase is a glutathione S-transferase composed of an 18-kDa polypeptide that is enzymatically active as a homodimer and may be phosphoregulated in vivo.
Leukotrienes (LTs) are potent lipid-derived mediators that are released in response to a variety of immunologic and inflammatory stimuli (1, 2) . The enzyme LTC4 synthase catalyzes the first committed step in the biosynthesis of the cysteinyl LTs (LTC4, LTD4, and LTE4) that collectively make up the slow-reacting substance of anaphylaxis and appear to play a pivotal role in the pathogenesis of human bronchial asthma (3) . LTC4 synthase is a membrane-bound glutathione S-transferase activity that is distinct from a, ,u, ir, 0, and microsomal glutathione S-transferases and appears to be exclusively committed to the biosynthesis of LTC4 (4) . Of the known human glutathione S-transferases, it is the only one that has not yet been purified to homogeneity or cloned, due predominantly to the extreme lability of LTC4 synthase in partially purified forms and the lack of a suitably abundant source of the enzyme. Recently, we have described the induction of high levels of LTC4 synthase activity in the human promonocytic leukemia cell line U937 after differentiation into monocyte/ macrophage-like cells by growth in the presence of dimethyl sulfoxide (Me2SO) (4) . From the microsomal membranes of these cells, LTC4 synthase was purified >10,000-fold and an 18-kDa membrane polypeptide was identified by photoaffinity labeling as a strong candidate for being LTC4 synthase or a subunit of the enzyme (5) . In this report, we describe the purification to homogeneity of human LTC4 synthase from the monocytic leukemia cell line THP-1 and show that like other known glutathione S-transferases, which are all low molecular mass dimeric or trimeric enzymes, human LTC4 synthase is composed of a single 18-kDa polypeptide that is functionally active as a homodimer.
MATERIALS AND METHODS
Cell Growth and Subcellular Fractionation. U937 and HL-60 cells were grown and differentiated as described (4) . Cells from the human monocytic leukemia cell line THP-1 (American Type Culture Collection TIB 202; ref. 6) were propagated in culture similarly except the medium was RPMI 1640 (supplemented with 0.2% NaHCO3, 0.03% L-glutamine, and 50 ,LM 2-mercaptoethanol) containing 10% (vol/vol) fetal bovine serum (Sigma Hybri-Max, not heat-inactivated), penicillin (50 units/ml), and streptomycin (50 ,ug/ml). Cells were harvested after 4-7 days in culture by continuous-flow centrifugation and ruptured by nitrogen cavitation (30 min at 800 psi; 1 psi = 6.9 kPa), and the 100,000 x g microsomal membrane fraction was isolated as described (5) .
Preparation of Membranes from Human Lung. Postmortem human lung samples were obtained from the International Institute for the Advancement of Medicine (Essington, PA). The 100,000 x g membrane fraction was isolated from homogenized parenchyma essentially as described (7) injected onto a HiLoad Q Sepharose HP 26/10 anionexchange column (Pharmacia, 2.6 x 10 cm) that had been equilibrated in buffer A {20 mM Tris-HCl, pH 7.4/1 mM EDTA/2 mM reduced glutathione/1 mM dithiothreitol/0.1% taurocholate/0.5% n-octyl glucoside (Boehringer Mannheim)/0.5% 3-[(3-cholamidopropyl)dimethylammonia]-1-propane sulfonate (CHAPS, Calbiochem)} at a flow rate of 10 ml/min. After washing the column with 300 ml of buffer A, bound proteins were eluted with a linear gradient of NaCl (0-1.0 M, 1200-ml gradient volume) in buffer A.
Chromatographic step 2: LTC2 affinity chromatography. The preparation of LTC2-X-biotin-streptavidin-agarose affinity resins has been described (5). LTC2, a stable analogue of the LTC4 synthase enzymatic product LTC4, was synthesized for use as an affinity ligand essentially as described (8) .
Biotin was linked to the a-amino group of the y-glutamate component of the LTC2 glutathione moiety by incubation with an N-hydroxysuccinimide ester ofbiotin having a spacer arm length of 2.24 nm [NHS-X-biotin; succinimidyl 6(biotinamido)hexanoic acid; Molecular Probes] to form LTC2-Xbiotin. LTC2-X-biotin was then immobilized on streptavidinagarose at a ligand concentration of 40 ,uM. The resulting LTC2-X-biotin-streptavidin-agarose affinity resin was packed into a Pharmacia HR 10/2 FPLC column (10 mm diameter x 4.5 mm bed height) and preequilibrated at 1.0 ml/min in running buffer B [20 mM Tris'HCl, pH 7.4/1 mM EDTA/1 mM dithiothreitol/0.1% taurocholate/0.5% n-octyl glucoside/0.5% CHAPS (similar to running buffer A except without reduced glutathione)]. The active fractions from the anion-exchange step were pooled (typically 20 ml in total) and diluted 1:5 into running buffer B to reduce NaCl and glutathione concentrations, both of which inhibited LTC4 synthase binding to the affinity resin. The preparation was then injected onto the LTC2 affinity column at a flow rate of 0.2 ml/min. After sample application, the flow rate was returned to 1.0 ml/min and the column was washed with 10 ml of running buffer B. LTC4 synthase was eluted with a linear NaCl/reduced glutathione cogradient (0-1.0 M NaCl and 0-4 mM reduced glutathione; 15-ml gradient in buffer B).
Chromatographic step 3: Gel-permeation chromatography. The active fractions from two LTC2 affinity column runs were combined (typically 6 ml in total), then concentrated on a YM10 ultrafiltration membrane (Amicon) to <0.25 ml, and subsequently injected onto a Superdex 75 HR 10/30 column (Pharmacia, 1 x 30 cm) that had been equilibrated in buffer C [20 mM Tris HCl, pH 7.4/1 mM EDTA/2 mM reduced glutathione/l mM dithiothreitol/0.1% taurocholate/0.5% n-octyl glucoside/0.5% CHAPS/0.25 M NaCl (similar to buffer A except also containing NaCl)]. LTC4 synthase activity was eluted isocratically at a flow rate of 0.25 ml/min. The Superdex 75 column was calibrated by performing an identical chromatographic separation of LTC4 synthase coinjected with a mixture of molecular mass standards (each at 0.4 mg). Fractions were collected throughout the chromatogram and the molecular mass standards were positively identified on silver-stained SDS/polyacrylamide gels. 18 -kDa LTC4 synthase polypeptide (=100 pmol) were pooled and incubated at room temperature for 48 h with end-over-end mixing in a tube that also contained a 3 x 5 mm sliver of a poly(vinylidene difluoride) membrane. The sliver was washed several times with water then used directly for sequencing. Conventional Edman degradation microsequencing was performed on a modified Applied Biosystems model 477A gas-phase sequencer equipped with a continuous-flow reactor (9) .
Miscellaneous Methods. Human monocytes were isolated from the blood of healthy human volunteers by using discontinuous Histopaque gradients as described (4) . Glutathione S-transferase activity was measured spectrophotometrically (10) . Microsomal glutathione S-transferase activity was measured in the presence of Triton X-100 after N-ethylmaleimide pretreatment (11, 12) . SDS/PAGE was performed using standard methods (13) and protein bands in gels were visualized by silver staining (14) . Silver-staining artifact bands (15) were identified in blank lanes containing SDS sample buffer only. Protein was determined as described (16) using bovine y-globulin as standard. In highly purified LTC4 synthase preparations where protein determination was not possible by this method, protein was estimated by laser densitometry of samples on silver-stained SDS/ polyacrylamide gels. Where indicated, LTC4 synthase activity is expressed as the mean ± SD. RESULTS THP-1 Cells Are an Abundant Source of LTC4 Synthase Activity. Human lung parenchyma membranes were found to contain a substantial amount of LTC4 synthase activity (316.5 ± 71.6 pmol of LTC4 formed per min per mg of protein, n = 4; Table 1 ). We have observed (4) that the specific activity of LTC4 synthase in the human promonocytic leukemia cell line U937 (39.9 + 16.7 pmol of LTC4 formed per min per mg; n = 8) was elevated 10-fold (to 399.0 ± 84.1 pmol of LTC4 formed per min per mg; n = 47) concomitantly with Me2SO-induced differentiation into monocyte/macrophage-like cells and was thus comparable to that found in human lung. We therefore tested for LTC4 synthase activity in related cell lines of monocytic lineage and found endogenously high levels of LTC4 synthase in the monocytic leukemia cell line THP-1 (302.0 + 62.0 pmol of LTC4 formed per min per mg; n = 9) without further differentiation.
Purification of Human LTC4 Synthase. As with Me2SO-differentiated U937 cells (4, 5) , LTC4 synthase activity in THP-1 cells was predominantly localized in the 100,000 x g microsomal membrane fraction and could be solubilized with high recovery (>90%) by the anionic detergent taurocholate Proc. Natl. Acad Sci. USA 90 (1993) (data not shown). A mixture of detergents, 0.1% taurocholate/0.5% n-octyl glucoside/0.5% CHAPS, was found to work well in all chromatographic steps and enabled the purification of LTC4 synthase from THP-1 cell membranes to homogeneity as described below.
In the first chromatographic step (anion exchange), taurocholate extract from THP-1 cell microsomal membranes (50 ml, containing 500-800 mg of protein) was applied to a quaternary aminoethyl anion-exchange column. The column was developed with a linear gradient of NaCl and LTC4 synthase activity was eluted at -0.2 M NaCl (Fig. 1) . The specific activity of LTC4 synthase was increased 25-to 35-fold over the taurocholate extract used as starting material and the yield in this step was generally 40-60%.
In a previous report (5), we described the development of an affinity column, LTC2-X-biotin-streptavidin-agarose, to which LTC4 synthase could be bound and eluted in an active form. The affinity ligand LTC2 (a stable analog ofthe product of the LTC4 synthase-catalyzed reaction) was first biotinylated via the primary amino group on the y-glutamate residue of the LTC2 glutathione moiety and then the biotinylated LTC2 was immobilized on streptavidin-agarose at 40 ,uM. The column containing the LTC2-X-biotin-streptavidinagarose was equilibrated in a chromatography buffer that was identical to that used for anion-exchange except that glutathione was omitted since it competed with the LTC2 affinity ligand for LTC4 synthase binding. The active fractions from anion-exchange chromatography were pooled, diluted 1:5 with chromatography buffer (to reduce the concentration of NaCl and glutathione, both of which prevented LTC4 synthase binding to the affinity column), and passed on to the affi'nity column at a low flow rate (Fig. 2) . The vast majority of the total protein went through the affinity column, whereas all of the LTC4 synthase activity was bound. The column was developed with a NaCl/reduced glutathione cogradient and LTC4 synthase activity was eluted at -0.3 M NaCl/1.2 mM FIG. 1. Anion-exchange chromatography. A taurocholate extract (50 ml) of the 100,000 x g membrane fraction from THP-1 cells was applied to a HiLoad 26/10 Q Sepharose anion-exchange column that had been equilibrated in buffer A. The column was developed with a linear gradient of NaCl in buffer A and was monitored by on-line measurement of A2,0 as indicated. Fractions (4 ml) were collected and subsequently assayed for LTC4 synthase activity (nmol of LTC4 formed per min per ml) in standard incubation mixtures. LTC4 synthase activity (e) was eluted from the column at -0.2 M NaCl in the region indicated by the hatched bar (to which Inset corresponds). The relative specific activity of LTC4 synthase in each fraction (o) was calculated with respect to the LTC4 synthase specific activity of the taurocholate extract used as starting material, which was set at 1.
reduced glutathione. LTC4 synthase activity was enriched 50-to 60-fold by this step with a yield of 5-15%.
The final chromatographic step in the purification ofhuman LTC4 synthase from THP-1 cell membranes was gel permeation chromatography through a Pharmacia Superdex 75 column (exclusion limit = Mr 100,000; selectivity range = Mr 3000-70,000). The active fractions from LTC2 affinity chromatography were pooled, concentrated to -250 ,ul by ultrafiltration using a YM10 membrane (Amicon), and then injected onto the column (Fig. 3) . LTC4 synthase specific activity was enriched a further 3-to 5-fold over the active fraction from the LTC2 affinity column, used as starting material, with a recovery of 20-30%o.
Properties of Purified Human LTC4 Synthase. A representative purification series is summarized in Table 2 . Beginning with 2 x 1011 THP-1 cells, LTC4 synthwse was purified >27,000-fold over intact cells. The yield was <1% due in part to the intentional use of only the very center fractions (generally accounting for less than or equal to two-thirds) of the activity peaks. The final preparation consisted of a single polypeptide of -18 kDa (Fig. 4) . It was judged to be homogeneous based on the presence of a single protein band on silver-stained SDS-denaturing gels (Fig. 4b) and on isoelectric focusing gels (data not shown) and by the presence of single phenylthiohydantoin amino acid products after each cycle of sequential Edman degradation (see below). Approx- LTC4 Synthase Is a Homodimer Composed of 18-kDa Subunits. As described above and in Fig. 4B , the >25,000-fold purified preparation of LTC4 synthase was composed of a single polypeptide. This polypeptide corresponds to an 18-kDa polypeptide from Me2SO-differentiated U937 cell membranes that was specifically photolabeled by 125I-labeled azido-LTC4, a radioiodinated photoreactive LTC4 photoaffinity probe (4, 5) . An apparently identical 18-kDa polypeptide was the only protein specifically labeled by 251I-labeled azido-LTC4 in THP-1 cell membranes (A.A., R.J.Z., A.W.F.-H., and D.W.N., unpublished data). The ability of various LTs to competitively inhibit LTC4 synthase activity in THP-1 cell microsomal membranes (LTC2 2 LTC4 > LTD4 > LTE4 > LTB4; A.A. et al., unpublished data) corresponded exactly with their ability to compete for photolabeling of the 18-kDa polypeptide in THP-1 cell membranes (Fig. 5) , lending further support to the identification of the 18-kDa polypeptide as LTC4 synthase. On calibrated gel-fitration columns, however, purified LTC4 synthase activity was eluted at a volume corresponding to 39.2 3.3 kDa (n = 12), twice the molecular mass of the 18-kDa polypeptide constituent of the active fractions (see Fig. 3 Inset). This was the case for two gel-fitration media where the native molec- ular mass was determined to be 37.5 ± 3.1 kDa (Pharmacia Superose 12; n = 5) and 40.4 ± 3.2 kDa (Pharmacia Superdex 75; n = 7). Although it is possible that the native molecular mass for LTC4 synthase was overestimated due to artifacts sometimes associated with the gel-filtration chromatography of detergent-solubiized membrane proteins, this does not appear to be the case since in some preparations of LTC4 synthase where activity was lost after LTC2 affinity chromatography, the 18-kDa polypeptide was eluted later at a volume corresponding to 15-20 kDa. Enzymatically active LTC4 synthase, therefore, appears to be a homodimer composed of two identical 18-kDa subunits.
N-Terminal Sequence of Human LTC4 Synthase. The pure 18-kDa LTC4 synthase polypeptide (Cs100 pmol, purified from 2 x 1011 THP-1 cells) was adsorbed onto a sliver of poly(vinylidene difluoride) membrane and the N-terminal sequence of the first 35 amino acids, representing an estimated 20o of the 18-kDa polypeptide, was determined by automated Edman degradation (Fig. 6) . The sequence was unique and was not homologous to any known sequences contained in available databases (as of January 27, 1993; was set at 100%6. The relative specific activity was calculated with respect to the LTC4 synthase specific activity in cells, which was set at 1.0. (5) . In the current study,
Val-Leu-Leu-Gln-Ala-Gly-Phe-Ser-Leu-Gln-Val-Iso-Ser-Ala -Ar-30 we have purified LTC4 synthase >25,000-fold to homogeneity from the human monocytic leukemia cell line THP-1 and found that LTC4 synthase has some similarities with other members of the glutathione S-transferase family of enzymes. In particular, LTC4 synthase is enzymatically active as a homodimer of two 18-kDa subunits, a common feature of other glutathione S-transferases that are multimeric enzymes composed of low molecular mass subunits (11, 18, 19) .
That the purified 18-kDa polypeptide is LTC4 synthase was further supported by photoaffinity labeling studies using 1251-labeled azido-LTC4. In crude membrane preparations from both Me2SO-differentiated U937 cells (4, 5) and THP-1 cells (A.A. et al., unpublished data), 1251-labeled azido-LTC4 specifically labeled an 18-kDa polypeptide that was elevated during Me2SO-induced differentiation of U937 cells concomitantly with LTC4 synthase activity and that was constitutively present in THP-1 cells without further differentiation, as was LTC4 synthase activity.
The N-terminal sequence of human LTC4 synthase was composed predominantly of hydrophobic amino acids, consistent with the membrane-bound localization of the enzyme. It contained an N-terminal methionine residue, indicating that human LTC4 synthase is probably not proteolytically processed during its biogenesis in vivo. Most interestingly, a consensus sequence for protein kinase C phosphorylation was present, suggesting that human LTC4 synthase may be a phosphoregulated enzyme. Phosphoregulation of LTC4 synthase may constitute a potentially important controlling mechanism that may substantially affect cysteinyl LT production in several inflammatory disease states. Preliminary results in our laboratories using HL-60 cells have demonstrated that phorbol 12-myristate 13-acetate, an activator of protein kinase C, abolished cysteinyl LT production in ionophore-challenged HL-60 cells, whereas inhibition could be prevented by the presence of the protein kinase C inhibitor staurosporine (S. Kargman, J.P.V., J. F. Evans, and D.W.N., unpublished data).
In summary, human LTC4 synthase, a homodimeric glutathione S-transferase composed of two identical 18-kDa subunits, has been purified to homogeneity. LTC4 synthase is responsible for the production of LTC4 and may, therefore, be a key controlling enzyme in the biosynthesis of inflammatory LT mediators.
